Cargando…

Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank

Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeleznik, Oana A., Kang, Jae H., Lasky-Su, Jessica, Eliassen, A. Heather, Frueh, Lisa, Clish, Clary B., Rosner, Bernard A., Elze, Tobias, Hysi, Pirro, Khawaja, Anthony, Wiggs, Janey L., Pasquale, Louis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199010/
https://www.ncbi.nlm.nih.gov/pubmed/37208353
http://dx.doi.org/10.1038/s41467-023-38466-w
_version_ 1785044840052948992
author Zeleznik, Oana A.
Kang, Jae H.
Lasky-Su, Jessica
Eliassen, A. Heather
Frueh, Lisa
Clish, Clary B.
Rosner, Bernard A.
Elze, Tobias
Hysi, Pirro
Khawaja, Anthony
Wiggs, Janey L.
Pasquale, Louis R.
author_facet Zeleznik, Oana A.
Kang, Jae H.
Lasky-Su, Jessica
Eliassen, A. Heather
Frueh, Lisa
Clish, Clary B.
Rosner, Bernard A.
Elze, Tobias
Hysi, Pirro
Khawaja, Anthony
Wiggs, Janey L.
Pasquale, Louis R.
author_sort Zeleznik, Oana A.
collection PubMed
description Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of developing POAG in a case-control study (599 cases and 599 matched controls) nested within the Nurses’ Health Studies, and Health Professionals’ Follow-Up Study. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 369 metabolites from 18 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 metabolites were measured in plasma samples from 2,238 prevalent glaucoma cases and 44,723 controls using NMR spectroscopy (Nightingale, Finland; version 2020). Here we show higher levels of diglycerides and triglycerides are adversely associated with glaucoma in all four cohorts, suggesting that they play an important role in glaucoma pathogenesis.
format Online
Article
Text
id pubmed-10199010
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101990102023-05-21 Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank Zeleznik, Oana A. Kang, Jae H. Lasky-Su, Jessica Eliassen, A. Heather Frueh, Lisa Clish, Clary B. Rosner, Bernard A. Elze, Tobias Hysi, Pirro Khawaja, Anthony Wiggs, Janey L. Pasquale, Louis R. Nat Commun Article Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of developing POAG in a case-control study (599 cases and 599 matched controls) nested within the Nurses’ Health Studies, and Health Professionals’ Follow-Up Study. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 369 metabolites from 18 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 metabolites were measured in plasma samples from 2,238 prevalent glaucoma cases and 44,723 controls using NMR spectroscopy (Nightingale, Finland; version 2020). Here we show higher levels of diglycerides and triglycerides are adversely associated with glaucoma in all four cohorts, suggesting that they play an important role in glaucoma pathogenesis. Nature Publishing Group UK 2023-05-19 /pmc/articles/PMC10199010/ /pubmed/37208353 http://dx.doi.org/10.1038/s41467-023-38466-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zeleznik, Oana A.
Kang, Jae H.
Lasky-Su, Jessica
Eliassen, A. Heather
Frueh, Lisa
Clish, Clary B.
Rosner, Bernard A.
Elze, Tobias
Hysi, Pirro
Khawaja, Anthony
Wiggs, Janey L.
Pasquale, Louis R.
Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title_full Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title_fullStr Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title_full_unstemmed Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title_short Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
title_sort plasma metabolite profile for primary open-angle glaucoma in three us cohorts and the uk biobank
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199010/
https://www.ncbi.nlm.nih.gov/pubmed/37208353
http://dx.doi.org/10.1038/s41467-023-38466-w
work_keys_str_mv AT zeleznikoanaa plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT kangjaeh plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT laskysujessica plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT eliassenaheather plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT fruehlisa plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT clishclaryb plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT rosnerbernarda plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT elzetobias plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT hysipirro plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT khawajaanthony plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT wiggsjaneyl plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT pasqualelouisr plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank
AT plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank